Exploratory Pilot Study Evaluating the Biologic Activity of Guanabenz in Bone Metastasis

Trial Profile

Exploratory Pilot Study Evaluating the Biologic Activity of Guanabenz in Bone Metastasis

Discontinued
Phase of Trial: Phase I

Latest Information Update: 07 Mar 2017

At a glance

  • Drugs Guanabenz (Primary)
  • Indications Bone metastases
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 02 Mar 2017 Status changed from active, no longer recruiting to discontinued.
    • 31 Aug 2016 Planned number of patients changed from 15 to 4.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top